angiomatosis need to be differentiated from pulmonary capillary haemangiomatois, seen in older children and adults.78 The latter is characterised by proliferation of capillary sized channels that infiltrate the lung interstitium and the walls of vessels and airways and leads to death from progressive pulmonary hypertension. Although the exact cause of these pulmonary vascular disorders is not clear, it has been suggested that they may represent an angiogenic disease-that is, lesions arising from non-neoplastic microvascular proliferation. 679 The concept of angiogenic disease is based on the discovery and characterisation of several angiogenic polypeptides that can stimulate or inhibit capillary growth and differentiation. 9 Several therapeutic strategies have been attempted in diffuse haemangiomatosis. Whether more patients with pulmonary haemangiomatosis will benefit from such treatment remains to be seen.
In summary, diffuse pulmonary angiomatosis is a rare clinical entity with an extremely poor prognosis. The possibility of this condition should be considered in a child with diffuse interstitial lung disease associated with increasing bloody pleural effusions. 
Abstract

